Answers are grounded in this paper and cite their sources.
Richard Steketee discusses the two studies by Clara Menendez and colleagues that describe using mefloquine for the intermittent preventative therapy of malaria in both HIV positive and HIV negative pregnant women and outlines the next steps. Please see later in the article for the Editors' Summary
No takes yet. Share an insight, caveat, or question.
Richard W. Steketee (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: